Hospitals and health systems face further deterioration of operating profits as new competitors emerge like CVS Health, Amazon, and other “non-traditional entrants” into the healthcare business, Fitch Ratings says in a new report.
Category: NASDAQ:ESRX
CVS To Return 100% Of Drug Rebates Under New PBM Price Model
CVS Caremark PBM will launch a new “guaranteed net cost” drug pricing model that will return 100% of rebates to health plan clients in a move to “predictability and pricing simplicity.”
Anthem’s PBM On Track for 2020 Launch
Anthem said its own pharmacy benefit manager, IngenioRx, “remains on track” to launch Jan. 1, 2020.
Centene Rolls Out RxAdvance PBM Promising Drug Cost Transparency
Centene has begun rolling out its new relationship with the pharmacy benefit manager, RxAdvance, a cloud-based PBM.
Rite Aid’s PBM Key To Any Revival
Rite Aid’s EnvisionRx PBM is targeting the booming business of aging baby boomers buying Medicare Part D drug plans.
Rite Aid Shakes Up Board, Strips CEO Of Chairmanship After Failed Merger
Rite Aid unveiled new governance, stripping CEO John Standley of the company’s chairmanship and adding new board members in the wake of a failed merger and mounting financial losses.
Pressure Mounts On Rite Aid To Find A Partner
Rite Aid faces intensifying pressure to find a strategic partner one month after its merger with Albertsons fell apart.
Justice Department Gives Early Okay To Cigna-Express Scripts Deal
U.S. Justice Department has cleared the Cigna and Express Scripts merger, “terminating the applicable waiting period,” the companies said Monday.
Cigna Launches $250M Fund To Invest In Start-Ups
Cigna is launching a $250 million venture fund to develop “startups and growth-stage companies,” the health insurer said.
WellCare Ready To Buy Divested CVS-Aetna Medicare Drug Plans
WellCare Health Plans is a potential buyer of Medicare part D drug plan assets that may have to be sold off by Aetna and CVS Health to win Justice Department approval of their merger.
